Posted on January 11, 2022 by adminJefferies says it’s time to buy these Indian pharmaceutical stocks, one with 20% upside Indian contract development and manufacturing companies are seeing “significant order flow improvement with strong growth visibility,” said Jefferies analysts. ( read original story …)